The effect of oral bisphosphonates on acute kidney injury, gastrointestinal events and hypocalcaemia in patients with chronic kidney disease

Oral bisphosphonates (oBP) are contraindicated in patients with severe chronic kidney disease (CKD), but there is a lack of data on safety in this area. We aimed to study the association between oBP use and risk of acute kidney injury (AKI), gastrointestinal events (GIE) and hypocalcaemia (HC) in pa...

全面介紹

書目詳細資料
Main Authors: Robinson, D, Ali, M, Pallares, N, Tebe, C, Cooper, C, Abrahamsen, B, Caskey, F, Ben-Shlomo, Y, Judge, A, Javaid, M, Diez-Perez, A, Prieto-Alhambra, D
格式: Conference item
出版: Springer London 2018

相似書籍